IPA analysis of MAM proteome predicts that XBP1 activation is suppressed, although the level of some individual target proteins is increased (Table 2); in contrast, the function of PERK/ATF4 pathway is significantly enhanced (p = 6.33E-03) (Table 3) in diabetes. The gene discussed is XBP1; the disease is diabetes mellitus.